Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.
about
Emerging Bcl-2 inhibitors for the treatment of cancer.Promising molecular targeted therapies in breast cancerSmall molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapyNucleic Acid Bioconjugates in Cancer Detection and Therapy.Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.A Polyethylenimine-Containing and Transferrin-Conjugated Lipid Nanoparticle System for Antisense Oligonucleotide Delivery to AML.Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cells.Harnessing the cell death pathway for targeted cancer treatment.Therapeutic targets in triple negative breast cancer.Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes.Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.Vectors and strategies for nonviral cancer gene therapy.Bacterial Toxins for Oncoleaking Suicidal Cancer Gene Therapy.Microarray determination of Bcl-2 family protein inhibition sensitivity in breast cancer cells.Pramanicin analog induces apoptosis in human colon cancer cells: critical roles for Bcl-2, Bim, and p38 MAPK signaling.Growth inhibition and chemosensitization of human carcinoma cells by human serum albumin-coated liposomal antisense oligodeoxyribonucleotide against bcl-2.WT1 silencing by RNAi synergizes with chemotherapeutic agents and induces chemosensitization to doxorubicin and cisplatin in B16F10 murine melanoma cells.An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.Quantitative analysis of survivin protein expression and its therapeutic depletion by an antisense oligonucleotide in human lung tumors.BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy.Application of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells.VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis.Star-Graft Quarterpolymer-Based Polymersomes as Nanocarriers for Co-Delivery of Hydrophilic/Hydrophobic Chemotherapeutic Agents
P2860
Q33682689-5A32C351-E4E8-42DF-9E31-E65F4BE3563AQ35040295-DF5CBB75-1A87-419E-87AB-4B72DBC4DACDQ35099238-A1B5026C-B32C-48C6-BC57-5C00D74F3501Q35867875-A928BFB6-1DDE-4F72-853C-E9CF2541EBEFQ36567569-4C314A3A-493B-4F45-93A7-0E667AD13847Q36726848-113E0CFD-2E14-4E3B-A8A7-7A3912BF4426Q37257494-D5F2CF3A-69D7-4676-900C-388569640FF7Q37942090-01C12DEC-2AA2-4BC4-B9B4-5F67EC4A2153Q38084287-26642D4F-3628-4D3C-BBCB-BC3ED4ADE958Q38107203-EEF20EB3-27B3-4008-810F-977E557277F6Q38563530-BF2FF36B-4D50-4696-841E-A8473330BAD4Q38694798-95D5796E-F45C-446F-B016-E98D693E7F40Q39094451-3B18E962-6DEE-4F20-A2C9-56A9EF9307B6Q39168078-83131D9B-1FCC-40D2-8E28-E658A8F6F324Q39188578-CD78384C-C42C-4A7F-927B-EBDFB8E5C6BAQ39288970-58FA3C97-C4FB-4F1A-B14D-57B67D11521CQ39323696-FE565208-60FE-4BD4-886D-482510D3ED8CQ40298219-11769C13-FABD-4691-A48D-BA3AA688760BQ42129596-96B095DF-2D66-4DB6-B0B2-8DA4C41E2598Q42471884-1130E8C1-4326-4623-832E-8A24B94C98C5Q45892685-029DA1F6-044F-4877-9C0A-A80400419A76Q55129102-62985AA0-F3B0-47D5-A069-F5B83AAE1A22Q57359361-1BD23073-C8BB-460A-98E8-EF3476012151
P2860
Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Phase I/II study of G3139 (Bcl ...... nd docetaxel in breast cancer.
@ast
Phase I/II study of G3139 (Bcl ...... nd docetaxel in breast cancer.
@en
type
label
Phase I/II study of G3139 (Bcl ...... nd docetaxel in breast cancer.
@ast
Phase I/II study of G3139 (Bcl ...... nd docetaxel in breast cancer.
@en
prefLabel
Phase I/II study of G3139 (Bcl ...... nd docetaxel in breast cancer.
@ast
Phase I/II study of G3139 (Bcl ...... nd docetaxel in breast cancer.
@en
P2093
P2860
P1476
Phase I/II study of G3139 (Bcl ...... and docetaxel in breast cancer
@en
P2093
Abenaa M Brewster
Cindy Lipsanen
Daniel J Booser
Gabriel N Hortobagyi
James Zwiebel
Kelly K Hunt
Linda Yuan
Massimo Cristofanilli
Stacy L Moulder
Thomas A Buchholz
P2860
P304
P356
10.1158/1078-0432.CCR-08-1104
P407
P577
2008-12-01T00:00:00Z